DiogenX’s EUR27.5 Million Serie A Fundraising

McDermott advised DiogenX in its fundraising.DiogenX, a biotechnology company specializing in the regeneration of beta cells that produce insulin for the treatment of diabetes, has announced…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Georgio Naffaa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here